# TRIUMEQ
> **NDA205551** · New Drug Application · Sponsor: VIIV HLTHCARE · Approved 2014-08-22
## Drug
- **FDA Application Number:** NDA205551
- **Application type:** New Drug Application
- **Brand name:** TRIUMEQ
- **Generic name:** ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE
- **Active ingredients:** ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** VIIV HLTHCARE
- **Manufacturer:** ViiV Healthcare Company
- **First approval:** 2014-08-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205551)
---
*AI Analytics · CC0 1.0*